SEATTLE, Wash. and VANCOUVER, British Columbia / ACCESSWIRE / May 4, 2021 / Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its first quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, May 13, 2021 at 4:30PM EDT.

To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 6096445. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.

Investor Relations Contact 
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4

Media Contact
Glenn Silver
Glenn.Silver@Finnpartners.com
(646) 871-8485

SOURCE: Achieve Life Sciences, Inc.